Clinical Conversations

This podcast features lively interviews, concise summaries, and expert commentary that busy clinicians need to stay current and improve patient care.

Articles matching the ‘LCZ696’ Category

September 9th, 2014

Podcast 174: PARADIGM and Heart Failure

The PARADIGM-HF trial of LCZ696 — a novel compound that both blocks the renin-angiotensin system with an ARB component and blocks neprilysin’s degradation of natriuretic peptides — increased survival in heart failure by some 20% relative to enalapril. It seems to be a big deal, and the trial’s two principal authors have agreed to talk […]

Categories: Heart failure, LCZ696, PARADIGM-HF trial, renin-angiotensin blockade, Uncategorized
Tags: , , , , , , , , ,

Clinical Conversations

About the Podcast

Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.

Follow us:
Follow on Apple Podcasts

Listen on Youtube

Follow on Spotify